Business Context and Reporting Period
Company: International Flavors & Fragrances Inc. (IFF)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2010
Business Overview: IFF is a leading creator and manufacturer of flavor and fragrance compounds for consumer products, organized into two segments: Flavors and Fragrances.
Key Financial Metrics
| Metric (in thousands) | Q1 2010 | Q1 2009 |
|---|---|---|
| Net Sales | $653,909 | $559,630 |
| Cost of Goods Sold | $383,702 | $337,565 |
| Gross Margin % | 41.3% | 39.7% |
| Operating Profit | $104,579 | $81,849 |
| Net Income | $63,789 | $47,197 |
| Diluted EPS | $0.80 | $0.60 |
| Operating Cash Flow | $32,392 | $(14,368) |
| Total Debt | $1,014,858 | $1,215,400 (approx. based on 2009 data) |
| Cash and Equivalents | $89,818 | $87,589 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 17% year-over-year. Local currency (LC) sales grew 13%, driven by customer re-stocking, new business wins, and demand recovery. Foreign currency movements contributed an additional 4% to reported growth.
- Segment Performance:
- Flavors: Sales up 13% (8% in LC); Operating profit rose to $61.6 million (20.5% margin) from $52.8 million (19.9% margin).
- Fragrances: Sales up 21% (18% in LC); Operating profit rose to $56.0 million (15.8% margin) from $36.8 million (12.5% margin).
- Cost Structure: Cost of goods sold as a percentage of sales improved to 58.7% from 60.3%, aided by favorable input costs and better volume absorption.
- Restructuring Charges: The company recorded $5.0 million in restructuring charges in Q1 2010, primarily related to the closure of a compounding facility in Drogheda, Ireland, and rationalization of European operations. No such charges were recorded in Q1 2009.
- Interest Expense: Decreased to $12.7 million from $19.8 million, reflecting debt repayments and the absence of a $4 million swap close-out cost incurred in the prior year.
Guidance, Outlook, and Risks
- Outlook: Management expects gross additions to property, plant, and equipment to approximate 4% of sales for the full year 2010. The company anticipates sufficient cash flows and credit facility availability to fund operations for at least the next 18 months.
- Restructuring Plan: Total expected costs for the ongoing restructuring plan are estimated at $27-$29 million. Approximately $19.2 million has been recorded since Q3 2009.
- Liquidity and Covenants: The company maintains a Net Debt to Adjusted EBITDA ratio of 1.95 to 1, well below the 3.25 to 1 covenant limit. The revolving credit facility has approximately $600 million in available capacity.
- Risks and Contingencies:
- Litigation: 13 actions involving 225 claimants regarding respiratory illness from flavor exposure are pending. Management believes accrued liabilities are adequate and does not expect a material adverse effect.
- Environmental: Estimated future costs for environmental remediation at ten sites are less than $5 million.
- Tax: $66 million in gross unrecognized tax benefits exist; the company may need to self-fund collateral for tax exposures if credit market conditions prevent securing external collateral.
Investor Verification Checklist
- Verify the sustainability of the 13% local currency sales growth, distinguishing between permanent demand recovery and temporary customer re-stocking.
- Monitor the execution and total cost of the European restructuring plan, specifically the $4 million increase in severance provisions.
- Review the status of pending flavor-related litigation to ensure accrued liabilities remain sufficient against potential verdicts.
- Assess the impact of foreign currency fluctuations on future margins, given the company's global exposure.
- Confirm compliance with debt covenants, specifically the Net Debt/Adjusted EBITDA ratio, in subsequent quarters.